WallStreetZenWallStreetZen

NYSEMKT: CLDI
Calidi Biotherapeutics Inc Stock Ownership - Who owns Calidi Biotherapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Calidi Biotherapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Allan CamaisaCEO and Chairman of the Board2024-12-1710,000$1.62
$16.20kSell
Allan CamaisaCEO and Chairman of the Board2024-09-2670,155$1.15
$80.68kBuy

1 of 1

CLDI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CLDI insiders and whales buy or sell their stock.

CLDI Shareholders

What type of owners hold Calidi Biotherapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Allan Camaisa28.20%8,965,668$3.09MInsider
Armistice Capital LLC10.45%3,322,000$1.15MInstitution
James A. Schoeneck6.40%2,035,668$702.31kInsider
Scott Leftwich6.24%1,985,417$684.97kInsider
First Light Acquisition Group LLC6.08%1,931,852$666.49kInsider
Polar Asset Management Partners Inc2.71%861,800$297.32kInsider
Thomas A. Vecchiolla2.23%708,792$244.53kInsider
Bank Of Montreal1.54%489,800$168.98kInstitution
Stephen Thesing1.48%471,544$162.68kInsider
Boris Radoslavov Minev1.34%424,458$146.44kInsider

1 of 3

CLDI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CLDI17.17%58.63%Net Buying
PHIO0.10%99.90%Net BuyingNet Buying
PHGE30.12%69.88%Net Buying
CSCI0.86%0.00%
BCDA0.13%99.87%Net BuyingNet Buying
View Top Biotech Stocks

Calidi Biotherapeutics Stock Ownership FAQ

Who owns Calidi Biotherapeutics?

Calidi Biotherapeutics (NYSEMKT: CLDI) is owned by 17.17% institutional shareholders, 58.63% Calidi Biotherapeutics insiders, and 24.20% retail investors. Allan Camaisa is the largest individual Calidi Biotherapeutics shareholder, owning 8.97M shares representing 28.20% of the company. Allan Camaisa's Calidi Biotherapeutics shares are currently valued at $3.09M.

If you're new to stock investing, here's how to buy Calidi Biotherapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.